High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia
Kongfei Li, Lieguang Chen, Hua Zhang, Lu Wang, Keya Sha, Xiaohong Du, Daiyang Li, Zhong-Zheng Zheng, Renzhi Pei, Ying Lu, Hongyan Tong
Abstract
is a potential biomarker for adverse outcomes in AML. The DEGs and pathways recognized in the study provide a preliminary grasp of the underlying molecular mechanisms of AML carcinogenesis and progression.
Topics & Concepts
NomogramNPM1Myeloid leukemiaProportional hazards modelOncologyCarcinogenesisBiologyInternal medicineMalignancyMyeloidLeukemiaSurvival analysisCancer researchCancerGeneMedicineGeneticsChromosomeKaryotypeAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentHistone Deacetylase Inhibitors Research